CDKN2A and gastric cancer: In summary, although the molecular alteration responsible for the occurrence of GX in the gastric mucosa remains unclear, GX is a powerful marker for prediction of the development of synchronous/metachronous GC, at least compared with molecular alterations of MSI or methylation of hMLH1, CDKN2A or APC in patients with early GC.